Access cutting-edge epilepsy treatment through this clinical trial at a research site in Savannah. Study-provided care at no cost to qualified participants.
Access epilepsy specialists in Savannah at no cost
This study follows strict safety protocols and ethical guidelines
All study-related epilepsy treatment provided free
Primary objective: To evaluate the safety and tolerability of cenobamate in pediatric subjects 2-17 years of age with partial-onset (focal) seizures
Sponsor: SK Life Science, Inc.
Check if you qualify for this epilepsy clinical trial in Savannah, GA
If you're searching for epilepsy treatment options in Savannah, GA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Savannah research site is actively enrolling participants for this clinical trial. You'll receive care from experienced epilepsy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.